Richardson P - Search Results

1

Multiple myeloma.

Laubach J, Richardson P, Anderson K. Laubach J, et al. Among authors: richardson p. Annu Rev Med. 2011;62:249-64. doi: 10.1146/annurev-med-070209-175325. Annu Rev Med. 2011. PMID: 21090965 Review.

2

Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma.

Davies FE, Raje N, Hideshima T, Lentzsch S, Young G, Tai YT, Lin B, Podar K, Gupta D, Chauhan D, Treon SP, Richardson PG, Schlossman RL, Morgan GJ, Muller GW, Stirling DI, Anderson KC. Davies FE, et al. Among authors: richardson pg. Blood. 2001 Jul 1;98(1):210-6. doi: 10.1182/blood.v98.1.210. Blood. 2001. PMID: 11418482

3

Thalidomide: emerging role in cancer medicine.

Richardson P, Hideshima T, Anderson K. Richardson P, et al. Annu Rev Med. 2002;53:629-57. doi: 10.1146/annurev.med.53.082901.104043. Annu Rev Med. 2002. PMID: 11818493 Review.

4

Identification of genes regulated by dexamethasone in multiple myeloma cells using oligonucleotide arrays.

Chauhan D, Auclair D, Robinson EK, Hideshima T, Li G, Podar K, Gupta D, Richardson P, Schlossman RL, Krett N, Chen LB, Munshi NC, Anderson KC. Chauhan D, et al. Among authors: richardson p. Oncogene. 2002 Feb 21;21(9):1346-58. doi: 10.1038/sj.onc.1205205. Oncogene. 2002. PMID: 11857078

5

NF-kappa B as a therapeutic target in multiple myeloma.

Hideshima T, Chauhan D, Richardson P, Mitsiades C, Mitsiades N, Hayashi T, Munshi N, Dang L, Castro A, Palombella V, Adams J, Anderson KC. Hideshima T, et al. Among authors: richardson p. J Biol Chem. 2002 May 10;277(19):16639-47. doi: 10.1074/jbc.M200360200. Epub 2002 Feb 28. J Biol Chem. 2002. PMID: 11872748

6

Biologic sequelae of nuclear factor-kappaB blockade in multiple myeloma: therapeutic applications.

Mitsiades N, Mitsiades CS, Poulaki V, Chauhan D, Richardson PG, Hideshima T, Munshi N, Treon SP, Anderson KC. Mitsiades N, et al. Among authors: richardson pg. Blood. 2002 Jun 1;99(11):4079-86. doi: 10.1182/blood.v99.11.4079. Blood. 2002. PMID: 12010810

7

Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications.

Mitsiades N, Mitsiades CS, Poulaki V, Chauhan D, Richardson PG, Hideshima T, Munshi NC, Treon SP, Anderson KC. Mitsiades N, et al. Among authors: richardson pg. Blood. 2002 Jun 15;99(12):4525-30. doi: 10.1182/blood.v99.12.4525. Blood. 2002. PMID: 12036884

8

Cytokines modulate telomerase activity in a human multiple myeloma cell line.

Akiyama M, Hideshima T, Hayashi T, Tai YT, Mitsiades CS, Mitsiades N, Chauhan D, Richardson P, Munshi NC, Anderson KC. Akiyama M, et al. Among authors: richardson p. Cancer Res. 2002 Jul 1;62(13):3876-82. Cancer Res. 2002. PMID: 12097303

9

Dose-intensive therapy for extensive-stage small cell lung cancer and extrapulmonary small cell carcinoma: long-term outcome.

Elias AD, Skarin AT, Richardson P, Ibrahim J, McCauley M, Frei E 3rd. Elias AD, et al. Among authors: richardson p. Biol Blood Marrow Transplant. 2002;8(6):326-33. Biol Blood Marrow Transplant. 2002. PMID: 12108918 Clinical Trial.

10

Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications.

Mitsiades CS, Mitsiades N, Poulaki V, Schlossman R, Akiyama M, Chauhan D, Hideshima T, Treon SP, Munshi NC, Richardson PG, Anderson KC. Mitsiades CS, et al. Among authors: richardson pg. Oncogene. 2002 Aug 22;21(37):5673-83. doi: 10.1038/sj.onc.1205664. Oncogene. 2002. PMID: 12173037

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results